Jeffrey Auletta, MD

Professor
The Ohio State University
Columbus, OH, United States

Disclosure(s): Ascella Health: Advisor/Consultant

Presentation(s):

• 633 - Incidence and Outcomes of Pediatric Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients Under Surveillance and Not Under Surveillance for Human Adenovirus (HAdV) in the Post-HCT Period

  Saturday, October 19, 2024
  3:30 PM – 3:45 PM US PT